117829-60-4|Jmv 170|(6S,9S,15S,18S,21S)-15-((1H-indol-3-yl)methyl)-9,18-dibutyl-21-carbamoyl-2,2-dimethyl-4,7,10,13,16,19-hexaoxo-20-phenethyl-6-(4-(sulfooxy)benzyl)-3-oxa-5,8,11,14,17,20-hexaazatricosan-23-oic acid|-范德生物科技公司

Jmv 170

NMR下载 COA and HPLC MSDS下载
names：
(6S,9S,15S,18S,21S)-15-((1H-indol-3-yl)methyl)-9,18-dibutyl-21-carbamoyl-2,2-dimethyl-4,7,10,13,16,19-hexaoxo-20-phenethyl-6-(4-(sulfooxy)benzyl)-3-oxa-5,8,11,14,17,20-hexaazatricosan-23-oic acid
CAS号：
117829-60-4
MDL Number：
MF(分子式)： C51H68N8O14S MW(分子量)： 1049.2
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Jmv 170
英文别名	Jmv 170; Jmv-170; Jmv170;
CAS号	117829-60-4
Inchi	InChI=1S/C51H68N8O14S/c1-6-8-18-38(56-47(65)40(58-50(68)72-51(3,4)5)27-33-21-23-35(24-22-33)73-74(69,70)71)46(64)54-31-43(60)55-41(28-34-30-53-37-20-14-13-17-36(34)37)48(66)57-39(19-9-7-2)49(67)59(42(45(52)63)29-44(61)62)26-25-32-15-11-10-12-16-32/h10-17,20-24,30,38-42,53H,6-9,18-19,25-29,31H2,1-5H3,(H2,52,63)(H,54,64)(H,55,60)(H,56,65)(H,57,66)(H,58,68)(H,61,62)(H,69,70,71)/t38-,39-,40-,41-,42-/m0/s1
InchiKey	UPHNCRZPDMOIDF-FDXDWZSASA-N
分子式 Formula	C51H68N8O14S
分子量 Molecular Weight	1049.2
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Jmv 170(CAS:117829-60-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Jmv 170 is the C-terminal heptapeptide of cholecystokinin in which the C-terminal pehnylalanine residue has been replaced by a phenylethylamide group; has partial agonist CCK activity on pancreatic amylase release.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Nagain C, Lignon MF, Galas MC, Rodriguez M, Martinez J, Rozé C. Large and prolonged in vivo response of pancreatic secretion to phenylethylamide and phenylethylester derivatives of Boc-[Nle28-Nle31]CCK(26-33) in the rat. Peptides. 1992 Nov-Dec;13(6):1127-32. PubMed PMID: 1494494.

[2]Gue M, Junien JL, Del Rio C, Bueno L. Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther. 1992 Jun;261(3):850-5. PubMed PMID: 1318376.

[3] Botella A, Delvaux M, Berry P, Frexinos J, Bueno L. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes. Gastroenterology. 1992 Mar;102(3):779-86. PubMed PMID: 1537515.

[4] Orosco M, Gourch A, Rodriguez M, Martinez J, Jacquot C, Cohen Y. Comparative activity of two cholecystokinin analogues with partial agonist activity: effects on food intake and brain monoamines. Peptides. 1990 Sep-Oct;11(5):873-7. PubMed PMID: 2284198.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开